Healthcare & Life Sciences
Seneca Therapeutics, Inc
United Stateswww.senecatherapeutics.com/
aliveseries-b
series-b
Stage
1
Investors
About
Seneca Therapeutics develops oncolytic immunotherapeutic candidates, including Seneca Valley Virus (SVV-001), that selectively target and treat solid tumors by replicating in tumor cells expressing the TEM8 receptor.
Explore Seneca Therapeutics, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.